CN115350133A - Preparation and application of skin-whitening and soothing nano-structure lipid carrier - Google Patents
Preparation and application of skin-whitening and soothing nano-structure lipid carrier Download PDFInfo
- Publication number
- CN115350133A CN115350133A CN202211056118.7A CN202211056118A CN115350133A CN 115350133 A CN115350133 A CN 115350133A CN 202211056118 A CN202211056118 A CN 202211056118A CN 115350133 A CN115350133 A CN 115350133A
- Authority
- CN
- China
- Prior art keywords
- whitening
- phase
- parts
- soothing
- lipid carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002632 lipids Chemical class 0.000 title claims abstract description 66
- 238000002360 preparation method Methods 0.000 title claims abstract description 37
- 239000002086 nanomaterial Substances 0.000 title claims abstract description 13
- 230000002087 whitening effect Effects 0.000 claims abstract description 91
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 52
- 239000008367 deionised water Substances 0.000 claims abstract description 18
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 18
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000004480 active ingredient Substances 0.000 claims description 32
- 238000003756 stirring Methods 0.000 claims description 31
- 239000000243 solution Substances 0.000 claims description 26
- 239000000284 extract Substances 0.000 claims description 25
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 24
- 244000186892 Aloe vera Species 0.000 claims description 24
- 235000011399 aloe vera Nutrition 0.000 claims description 24
- 210000003022 colostrum Anatomy 0.000 claims description 20
- 235000021277 colostrum Nutrition 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 241000218394 Magnolia liliiflora Species 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- 239000000839 emulsion Substances 0.000 claims description 12
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 11
- 239000000969 carrier Substances 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 10
- 239000002244 precipitate Substances 0.000 claims description 10
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 9
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 9
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 8
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 8
- 239000000287 crude extract Substances 0.000 claims description 8
- 229940016667 resveratrol Drugs 0.000 claims description 8
- 235000021283 resveratrol Nutrition 0.000 claims description 8
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 7
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 7
- AMUTYVGRCVFCCD-UHFFFAOYSA-N 5,6-diaminopyridine-3-carboxylic acid Chemical compound NC1=CC(C(O)=O)=CN=C1N AMUTYVGRCVFCCD-UHFFFAOYSA-N 0.000 claims description 7
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 7
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 7
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 claims description 7
- 229940033280 alpha-arbutin Drugs 0.000 claims description 7
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims description 7
- 229940057910 shea butter Drugs 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 6
- 230000032683 aging Effects 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 210000002615 epidermis Anatomy 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000012071 phase Substances 0.000 claims 26
- 238000001816 cooling Methods 0.000 claims 4
- 238000010438 heat treatment Methods 0.000 claims 4
- 238000002156 mixing Methods 0.000 claims 3
- 235000019441 ethanol Nutrition 0.000 claims 2
- 238000004806 packaging method and process Methods 0.000 claims 2
- 239000008346 aqueous phase Substances 0.000 claims 1
- 238000005520 cutting process Methods 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- 238000010348 incorporation Methods 0.000 claims 1
- 230000001376 precipitating effect Effects 0.000 claims 1
- 238000010008 shearing Methods 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 239000002537 cosmetic Substances 0.000 abstract description 8
- 239000013543 active substance Substances 0.000 abstract description 3
- 230000007794 irritation Effects 0.000 abstract 2
- 239000007844 bleaching agent Substances 0.000 abstract 1
- 239000007854 depigmenting agent Substances 0.000 abstract 1
- 238000005562 fading Methods 0.000 abstract 1
- 239000004519 grease Substances 0.000 abstract 1
- 230000007246 mechanism Effects 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 36
- 210000002257 embryonic structure Anatomy 0.000 description 34
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 24
- 241000252212 Danio rerio Species 0.000 description 20
- 235000014104 aloe vera supplement Nutrition 0.000 description 18
- 241000218378 Magnolia Species 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 235000002316 solid fats Nutrition 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 241000251468 Actinopterygii Species 0.000 description 7
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000013011 mating Effects 0.000 description 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012490 blank solution Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- IGGVVGHJSQSLFO-UHFFFAOYSA-N indole-5,6-quinone Chemical compound O=C1C(=O)C=C2C=CNC2=C1 IGGVVGHJSQSLFO-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000234479 Narcissus Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003157 biological pigment Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000036564 melanin content Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- -1 resveratrol Chemical compound 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种美白舒缓的纳米结构脂质载体的制备方法,同时也涉及该美白舒缓的纳米结构脂质载体作为化妆品主要有效成分的应用,属于日用护肤品技术领域。The invention relates to a preparation method of a whitening and soothing nanostructured lipid carrier, and also relates to the application of the whitening and soothing nanostructured lipid carrier as a main active ingredient of cosmetics, belonging to the technical field of daily skin care products.
背景技术Background technique
爱美之心人皆有之,皮肤白皙是东方女性的普遍诉求之一。追求“美白”,主要是从四个方面抑制黑色素:一是阻碍黑色素生成。黑色素是由黑色素细胞分泌的生物色素,它是由酪氨酸经过酪氨酸酶作用,氧化生成多巴,多巴经氧化、脱羧等反应转变成吲哚醌,最后吲哚醌聚合为黑色素。通过使用美白功效成分化妆品,可以从源头减缓黑色素生成,如熊果苷等;二是抑制酪氨酸酶活性,调节黑色素形成的信号通路与微噬菌体相关转录因子(MITF)有关,下调MITF活性可以降低相关酶的表达,从而抑制黑色素的形成,如白藜芦醇、水仙鳞茎醇提取物等;三是抑制黑色素的转移,阻止黑色素向上层角质形成细胞的转移,如烟酰胺等;四是促进新陈代谢,去除黑色素角质细胞,使皮肤恢复白皙,如各种酸类等。Everyone has a desire for beauty, and fair skin is one of the common demands of oriental women. The pursuit of "whitening" mainly inhibits melanin from four aspects: one is to hinder the production of melanin. Melanin is a biological pigment secreted by melanocytes. It is oxidized to dopa by tyrosine through the action of tyrosinase. Dopa is converted into indole quinone through oxidation, decarboxylation and other reactions, and finally indole quinone is polymerized into melanin. By using cosmetics with whitening functional ingredients, melanin production can be slowed down from the source, such as arbutin, etc.; the second is to inhibit tyrosinase activity, the signaling pathway that regulates melanin formation is related to microphage-related transcription factor (MITF), and down-regulating MITF activity can Reduce the expression of related enzymes, thereby inhibiting the formation of melanin, such as resveratrol, narcissus bulb alcohol extract, etc.; the third is to inhibit the transfer of melanin, preventing the transfer of melanin to the upper keratinocytes, such as nicotinamide, etc.; the fourth is to promote Metabolize, remove melanin keratinocytes, restore fair skin, such as various acids, etc.
发明内容Contents of the invention
本发明所要解决的技术问题在于提供一种美白舒缓的纳米结构脂质载体的制备方法,其步骤至少包括:The technical problem to be solved by the present invention is to provide a method for preparing a whitening and soothing nanostructured lipid carrier, the steps of which at least include:
步骤1:紫玉兰叶提取物的制备Step 1: Preparation of Purple Magnolia Leaf Extract
将新鲜的紫玉兰叶进行清洗干净后,沥水烘干;干燥至表面无水分,低于原始重量的70%之后,用研磨机将其研磨成紫玉兰叶粉末;After cleaning the fresh purple magnolia leaves, drain and dry them; dry them until the surface is free of moisture, which is less than 70% of the original weight, and then use a grinder to grind them into purple magnolia leaf powder;
将干燥的紫玉兰叶粉末用无水乙醇超声破碎提取3次,合并提取液,减压蒸馏去除有机溶剂后得到紫玉兰叶提取物;The dried magnolia leaf powder was ultrasonically crushed and extracted with absolute ethanol for 3 times, the extracts were combined, and the organic solvent was distilled off under reduced pressure to obtain the magnolia leaf extract;
步骤2:库拉索芦荟提取物的制备Step 2: Preparation of Aloe Vera Extract
将库拉索芦荟反复冲洗干净,表面擦干后剔除其边刺,将表皮从透明的凝胶表面剥离,用清水洗去凝胶表面的黄色汁液;Rinse the aloe vera repeatedly, dry the surface and remove its side thorns, peel off the epidermis from the transparent gel surface, and wash off the yellow juice on the gel surface with water;
将库拉索芦荟切成小块,用组织搅拌机搅成匀浆,匀浆液离心12000r/min,15min后除去沉淀,得到库拉索芦荟凝胶汁;Cut the aloe vera into small pieces, stir it into a homogenate with a tissue mixer, centrifuge the homogenate at 12000r/min, remove the precipitate after 15min, and obtain the aloe vera gel juice;
将库拉索芦荟凝胶汁在旋转蒸发仪中,在60℃的条件下真空浓缩到原体积的35%后,再加入10倍体积的95%乙醇,降温至4℃下醇沉24h;Concentrate the aloe vera gel juice in a rotary evaporator to 35% of the original volume in vacuum at 60°C, then add 10 times the volume of 95% ethanol, and cool down to 4°C for alcohol precipitation for 24 hours;
将得到的库拉索芦荟混合沉淀物按5000r/min转速离心15min,收集沉淀物,冷冻干燥即得库拉索芦荟粗提取物;The obtained Aloe Vera mixed sediment was centrifuged at a speed of 5000r/min for 15min, the precipitate was collected, and freeze-dried to obtain the Aloe Vera crude extract;
将10g库拉索芦荟粗提取物溶解于1000mL去离子水中制备1.0%的水溶液;10g of Aloe vera crude extract was dissolved in 1000mL of deionized water to prepare a 1.0% aqueous solution;
在室温中向上述溶液中缓慢加入硫酸铵溶液并快速搅拌至库拉索芦荟粗提取物溶液中硫酸铵的质量分数达到40%,将混合产物置于4℃环境中放置24h;Slowly add ammonium sulfate solution to the above solution at room temperature and stir rapidly until the mass fraction of ammonium sulfate in the Aloe vera crude extract solution reaches 40%, and place the mixed product at 4°C for 24 hours;
然后将上述产物在5000r/min转速下离心15min,将离心产生的沉淀复溶于水并透析至无硫酸铵残留,经过冷冻干燥后得到库拉索芦荟提取物;Then the above product was centrifuged at 5000r/min for 15min, the precipitate produced by centrifugation was redissolved in water and dialyzed until there was no ammonium sulfate residue, and the Aloe vera extract was obtained after freeze-drying;
步骤3:物料准备Step 3: Material Preparation
按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:
10~30份美白活性成分、10~20份舒缓活性成分、25~36份油相的组分、1~4份乳化剂为,余量为去离子水;10-30 parts of whitening active ingredients, 10-20 parts of soothing active ingredients, 25-36 parts of oil phase components, 1-4 parts of emulsifier, and the balance is deionized water;
其中舒缓活性成分步骤1和2的方法所制备的紫玉兰叶提取物和库拉索芦荟提取物;Wherein the purple magnolia leaf extract and the aloe vera extract prepared by the method of
步骤4:制备油相Step 4: Prepare the Oil Phase
将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温60~80℃,得到油相;The whitening active ingredient, the soothing active ingredient and the components of the oil phase in step 3 are heated and stirred to dissolve, and kept at 60-80°C to obtain the oil phase;
步骤5:制备水相Step 5: Prepare the Water Phase
将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温60~80℃,得到水相;The emulsifier and deionized water in step 3 are heated and stirred to dissolve, and kept at 60-80°C to obtain the water phase;
步骤6:制备初乳Step 6: Prepare Colostrum
将由步骤5得到的水相在剪切力为10000~16000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质2~10min,得到初乳;Slowly add the water phase obtained in step 5 into the oil phase obtained in step 4 under the action of a shear force of 10,000-16,000 r/min, and then homogenize for 2-10 minutes to obtain colostrum;
步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers
将步骤6得到的初乳,通过高压均质机在压力为500~800bar作用下均质2~5次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 is homogenized 2 to 5 times by a high-pressure homogenizer under the action of a pressure of 500-800 bar, and rapidly cooled to room temperature to obtain a whitening and soothing nano-structured lipid carrier.
具体的,所述美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。Specifically, the particle size of the whitening and soothing nanostructured lipid carrier is between 200nm and 600nm.
具体的,所述美白活性成分为5~15份α-熊果苷和5~15份白藜芦醇。Specifically, the whitening active ingredient is 5-15 parts of α-arbutin and 5-15 parts of resveratrol.
具体的,所述油相的组分为10~16份乳木果油、5~11份单甘脂、10~15份月桂醇、1~6份辛酸癸酸甘油三酯、2~8份棕榈酸异辛酯。Specifically, the components of the oil phase are 10-16 parts of shea butter, 5-11 parts of monoglyceride, 10-15 parts of lauryl alcohol, 1-6 parts of caprylic and capric triglycerides, 2-8 parts of Isooctyl Palmitate.
具体的,所述乳化剂为:1~4份司盘83和2~3份吐温80。Specifically, the emulsifier is: 1-4 parts of Span 83 and 2-3 parts of Tween 80.
利用所述美白舒缓的纳米结构脂质载体参与制备的一种美白乳液,该美白乳液按质量百分比计包括以下组分:A whitening emulsion prepared by using the whitening and soothing nano-structured lipid carrier, the whitening emulsion includes the following components by mass percentage:
利用所述美白舒缓的纳米结构脂质载体参与制备的一种美白乳液,其制备方法包括如下步骤:A kind of whitening emulsion that utilizes the described whitening and soothing nanostructure lipid carrier to participate in the preparation, and its preparation method comprises the following steps:
将A相、B相、C相的各个组分分别搅拌混合后备用;首先将A和B两相分别加热至80℃,溶解混合均匀,将A相加入到B相中,并均质5min,在转速为8000rpm/min搅拌,随后冷却至50℃时,加入C相并均质2min,陈化24h后包装即可。Stir and mix the components of Phase A, Phase B, and Phase C separately and set aside; first, heat Phase A and Phase B to 80°C, dissolve and mix evenly, add Phase A to Phase B, and homogenize for 5 minutes. Stir at a rotation speed of 8000rpm/min, then cool to 50°C, add phase C and homogenize for 2min, age for 24h and pack.
利用所述美白舒缓的纳米结构脂质载体参与制备的一种美白面膜液,按质量百分比计包括以下组分:A kind of whitening facial mask liquid prepared by utilizing the nano-structured lipid carrier for whitening and soothing, comprising the following components by mass percentage:
利用所述美白舒缓的纳米结构脂质载体参与制备的一种美白面膜液,其制备方法包括如下步骤:A kind of whitening facial mask liquid that utilizes the nanostructure lipid carrier of described whitening and soothing to participate in the preparation, and its preparation method comprises the following steps:
将A相、B相、C相的各个组分分别搅拌混合后备用;依次将A、B两相称好,将A和B相加热至80℃,溶解到无颗粒,转速为1000rpm/min搅拌均匀,将B相加入到A相中,均质5min,搅拌降温至50℃,加入C相,转速为800rpm/min低速均质2min,陈化24h后包装即可。Stir and mix the components of Phase A, Phase B and Phase C separately and set aside; weigh Phases A and B in sequence, heat Phases A and B to 80°C, dissolve until there are no particles, and stir evenly at a speed of 1000rpm/min , add phase B to phase A, homogenize for 5 minutes, stir and cool down to 50°C, add phase C, homogenize at a low speed of 800rpm/min for 2min, age for 24h and pack.
与现有技术相比较,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明利用消费者对美白功效化妆品的需求,结合肌肤的敏感性,制备了一种兼具美白和舒缓功效的纳米结构脂质载体,让消费者在爱美的同时,降低因敏感肌带来的困扰。本发明所制备的产品,将活性物包裹在纳米结构脂质载体中兼具有美白和舒缓功效,使载体具有美白功效的同时,也能起到舒缓功效作用,降低皮肤刺激。The present invention utilizes consumers' needs for whitening cosmetics and combines skin sensitivity to prepare a nanostructured lipid carrier with both whitening and soothing effects, allowing consumers to reduce the troubles caused by sensitive skin while loving beauty . The product prepared by the invention has both whitening and soothing effects by encapsulating the active substance in the nanostructured lipid carrier, so that the carrier can not only have the whitening effect, but also play a soothing effect and reduce skin irritation.
附图说明Description of drawings
图1为对应浓度下美白舒缓的纳米结构脂质载体(样品1)、未包覆活性物纳米结构脂质载体的原料溶液(样品2)对斑马鱼胚胎安全性的影响示意图(P<0.01**;P<0.001***);Figure 1 is a schematic diagram of the effect of the whitening and soothing nanostructured lipid carrier (sample 1) and the raw material solution (sample 2) of the nanostructured lipid carrier not coated with active substances on the safety of zebrafish embryos at corresponding concentrations (P<0.01* *; P<0.001***);
图2为对应浓度下美白舒缓的纳米结构脂质载体对斑马鱼胚胎美白效果的影响示意图(P<0.01**;P<0.001***;P<0.0001****);Figure 2 is a schematic diagram of the effect of whitening and soothing nanostructured lipid carriers on the whitening effect of zebrafish embryos at corresponding concentrations (P<0.01**; P<0.001***; P<0.0001****);
图3为不同浓度下美白舒缓的纳米结构脂质载体对斑马鱼胚胎舒缓功效的影响示意图(P<0.0001****)。Figure 3 is a schematic diagram of the effect of different concentrations of whitening and soothing nanostructured lipid carriers on the soothing effect of zebrafish embryos (P<0.0001****).
具体实施方式Detailed ways
下面将结合附图对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明的一部分实施例,而不是全部的实施例。基于本发明提供的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions of the present invention will be clearly and completely described below in conjunction with the accompanying drawings. Apparently, the described embodiments are part of the embodiments of the present invention, not all of them. Based on the embodiments provided by the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts fall within the protection scope of the present invention.
在本发明的描述中,需要说明的是,术语“中心”、“上”、“下”、“左”、“右”、“竖直”、“水平”、“内”、“外”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本发明和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。此外,术语“第一”、“第二”、“第三”仅用于描述目的,而不能理解为指示或暗示相对重要性。In the description of the present invention, it should be noted that the terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer" etc. The indicated orientation or positional relationship is based on the orientation or positional relationship shown in the drawings, and is only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the referred device or element must have a specific orientation, or in a specific orientation. construction and operation, therefore, should not be construed as limiting the invention. In addition, the terms "first", "second", and "third" are used for descriptive purposes only, and should not be construed as indicating or implying relative importance.
在本发明的描述中,需要说明的是,除非另有明确的规定和限定,术语“安装”、“相连”、“连接”应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是机械连接,也可以是电连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域的普通技术人员而言,可以具体情况理解上述术语在本发明中的具体含义。In the description of the present invention, it should be noted that unless otherwise specified and limited, the terms "installation", "connection" and "connection" should be understood in a broad sense, for example, it can be a fixed connection or a detachable connection. Connected, or integrally connected; it can be mechanically connected or electrically connected; it can be directly connected or indirectly connected through an intermediary, and it can be the internal communication of two components. Those of ordinary skill in the art can understand the specific meanings of the above terms in the present invention in specific situations.
实施例:紫玉兰叶提取物的制备Embodiment: the preparation of purple magnolia leaf extract
步骤1:处理紫玉兰叶Step 1: Processing the Purple Magnolia Leaves
将新鲜的紫玉兰叶进行清洗干净后,沥水烘干。干燥至表面无水分,低于原始重量的70%之后,用研磨机将其研磨成紫玉兰叶粉末。After washing the fresh purple magnolia leaves, drain and dry them. After drying until the surface is free of moisture and less than 70% of the original weight, it is ground into purple magnolia leaf powder with a grinder.
步骤2:紫玉兰叶的提取Step 2: Extraction of Purple Magnolia Leaves
将干燥的紫玉兰叶粉末用无水乙醇超声破碎提取3次,合并提取液,减压蒸馏去除有机溶剂后得到紫玉兰叶提取物。The dried magnolia leaf powder was ultrasonically crushed and extracted three times with absolute ethanol, the extracts were combined, and the organic solvent was distilled off under reduced pressure to obtain the magnolia leaf extract.
实施例:库拉索芦荟提取物的制备Example: Preparation of Aloe Vera Extract
步骤1:处理库拉索芦荟Step 1: Processing Aloe Vera
将库拉索芦荟反复冲洗干净,表面擦干后剔除其边刺,将表皮从透明的凝胶表面剥离,用清水洗去凝胶表面的黄色汁液。Rinse the aloe vera repeatedly, dry the surface and remove its side thorns, peel off the epidermis from the transparent gel surface, and wash off the yellow juice on the gel surface with water.
步骤2:库拉索芦荟的提取Step 2: Extraction of Aloe Vera
将库拉索芦荟切成小块,用组织搅拌机搅成匀浆,匀浆液离心12000r/min,15min后除去沉淀,得到库拉索芦荟凝胶汁。Cut the aloe vera into small pieces, stir it into a homogenate with a tissue mixer, centrifuge the homogenate at 12000r/min, remove the precipitate after 15min, and obtain the aloe vera gel juice.
将库拉索芦荟凝胶汁在旋转蒸发仪中,在60℃的条件下真空浓缩到原体积的35%后,再加入10倍体积的95%乙醇,降温至4℃下醇沉24h。The aloe vera gel juice was vacuum-concentrated to 35% of the original volume at 60°C in a rotary evaporator, then 10 times the volume of 95% ethanol was added, and the temperature was lowered to 4°C for alcohol precipitation for 24 hours.
将得到的库拉索芦荟混合沉淀物按5000r/min转速离心15min,收集沉淀物,冷冻干燥即得库拉索芦荟粗提取物。The obtained Aloe vera mixed sediment was centrifuged at a speed of 5000r/min for 15min, the precipitate was collected, and freeze-dried to obtain a crude Aloe vera extract.
步骤3:库拉索芦荟提取物的分离纯化Step 3: Separation and Purification of Aloe Vera Extract
将10g库拉索芦荟粗提取物溶解于1000mL去离子水中制备1.0%的水溶液。A 1.0% aqueous solution was prepared by dissolving 10 g of Aloe vera crude extract in 1000 mL of deionized water.
在室温中向上述溶液中缓慢加入硫酸铵溶液并快速搅拌硫酸铵溶液并快速搅拌至库拉索芦荟粗提取物溶液中硫酸铵的质量分数达到40%后,将混合产物置于4℃环境中放置24h。Slowly add ammonium sulfate solution to the above solution at room temperature and stir the ammonium sulfate solution rapidly until the mass fraction of ammonium sulfate in the Aloe vera crude extract solution reaches 40%, then place the mixed product in a 4°C environment Leave it for 24h.
然后将上述产物在5000r/min转速下离心15min,将离心产生的沉淀复溶于水并透析至无硫酸铵残留,经过冷冻干燥后得到库拉索芦荟提取物。Then the above product was centrifuged at 5000r/min for 15min, the centrifuged precipitate was redissolved in water and dialyzed until no ammonium sulfate remained, and the Aloe vera extract was obtained after freeze-drying.
以下实施例中均采用上述方法制备的紫玉兰叶提取物和库拉索芦荟提取物。The magnolia leaf extract and Aloe vera extract prepared by the above method were used in the following examples.
实施例1Example 1
制备紫玉兰叶提取物和库拉索芦荟提取物的步骤不再重复。The steps for preparing the magnolia leaf extract and the aloe vera extract are not repeated.
步骤3:物料准备Step 3: Material Preparation
按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:
美白活性成分包括:8份α-熊果苷、6份白藜芦醇。Whitening active ingredients include: 8 parts of α-arbutin, 6 parts of resveratrol.
舒缓活性成分包括:6份紫玉兰叶提取物、8份库拉索芦荟提取物。Soothing active ingredients include: 6 parts Magnolia Leaf Extract, 8 parts Aloe Vera Extract.
油相的组分包括固体油脂和液体油脂。The components of the oil phase include solid fats and liquid fats.
固体油脂包括:11份乳木果油、7份单甘脂、10份月桂醇。Solid fats include: 11 parts of shea butter, 7 parts of monoglyceride, and 10 parts of lauryl alcohol.
液体油脂包括:2份辛酸癸酸甘油三酯、4份棕榈酸异辛酯。Liquid oils include: 2 parts caprylic capric triglyceride, 4 parts isooctyl palmitate.
乳化剂为:2份的司盘83、1份的吐温80,The emulsifier is: 2 parts of Span 83, 1 part of
再加入35份去离子水补足重量份数。Then add 35 parts of deionized water to make up the parts by weight.
步骤4:制备油相Step 4: Prepare the Oil Phase
将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温60℃,得到油相;The whitening active ingredient, the soothing active ingredient and the oil phase components in step 3 are heated and stirred to dissolve, and kept at 60°C to obtain the oil phase;
步骤5:制备水相Step 5: Prepare the Water Phase
将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温60℃,得到水相;Heat and stir the emulsifier and deionized water in step 3 to dissolve, and keep warm at 60°C to obtain the water phase;
步骤6:制备初乳Step 6: Prepare Colostrum
将由步骤5得到的水相在剪切力为12000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质4min,得到初乳;Slowly add the water phase obtained in step 5 to the oil phase obtained in step 4 under the shear force of 12000r/min, and then homogenize for 4 minutes to obtain colostrum;
步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers
将步骤6得到的初乳,通过高压均质机在压力为500bar作用下均质4次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 is homogenized 4 times by a high-pressure homogenizer under a pressure of 500 bar, and rapidly cooled to room temperature to obtain a whitening and soothing nano-structured lipid carrier.
检测美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。The particle size of the whitening and soothing nano-structured lipid carrier is detected to be between 200nm and 600nm.
实施例2Example 2
制备紫玉兰叶提取物和库拉索芦荟提取物的步骤不再重复。The steps for preparing the magnolia leaf extract and the aloe vera extract are not repeated.
步骤3:物料准备Step 3: Material Preparation
按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:
美白活性成分包括:8份α-熊果苷、6份白藜芦醇。Whitening active ingredients include: 8 parts of α-arbutin, 6 parts of resveratrol.
舒缓活性成分包括:7份紫玉兰叶提取物、8份库拉索芦荟提取物。Soothing active ingredients include: 7 parts Magnolia Leaf Extract, 8 parts Aloe Vera Extract.
油相的组分包括固体油脂和液体油脂。The components of the oil phase include solid fats and liquid fats.
固体油脂包括:11份乳木果油、7份单甘脂、10份月桂醇。Solid fats include: 11 parts of shea butter, 7 parts of monoglyceride, and 10 parts of lauryl alcohol.
液体油脂包括:2份辛酸癸酸甘油三酯、4份棕榈酸异辛酯。Liquid oils include: 2 parts caprylic capric triglyceride, 4 parts isooctyl palmitate.
乳化剂为:1份的司盘83、2份的吐温80,The emulsifier is: 1 part of
再加入34份去离子水补足重量份数。Then add 34 parts of deionized water to make up the parts by weight.
步骤4:制备油相Step 4: Prepare the Oil Phase
将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温65℃,得到油相;Heat and stir the whitening active ingredient, soothing active ingredient and components of the oil phase in step 3 to dissolve, and keep warm at 65°C to obtain the oil phase;
步骤5:制备水相Step 5: Prepare the Water Phase
将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温65℃,得到水相;Heat and stir the emulsifier and deionized water in step 3 to dissolve, keep warm at 65°C to obtain the water phase;
步骤6:制备初乳Step 6: Prepare Colostrum
将由步骤5得到的水相在剪切力为14000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质5min,得到初乳;Slowly add the water phase obtained in step 5 into the oil phase obtained in step 4 under the shear force of 14000r/min, and then homogenize for 5 minutes to obtain colostrum;
步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers
将步骤6得到的初乳,通过高压均质机在压力为500bar作用下均质5次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 is homogenized 5 times by a high-pressure homogenizer under the action of a pressure of 500 bar, and rapidly cooled to room temperature to obtain a whitening and soothing nano-structured lipid carrier.
检测美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。The particle size of the whitening and soothing nano-structured lipid carrier is detected to be between 200nm and 600nm.
实施例3Example 3
制备紫玉兰叶提取物和库拉索芦荟提取物的步骤不再重复。The steps for preparing the magnolia leaf extract and the aloe vera extract are not repeated.
步骤3:物料准备Step 3: Material Preparation
按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:
美白活性成分包括:10份α-熊果苷、10份白藜芦醇。Whitening active ingredients include: 10 parts of α-arbutin, 10 parts of resveratrol.
舒缓活性成分包括:10份紫玉兰叶提取物、10份库拉索芦荟提取物。Soothing active ingredients include: 10 parts Magnolia Leaf Extract, 10 parts Aloe Vera Extract.
油相的组分包括固体油脂和液体油脂。The components of the oil phase include solid fats and liquid fats.
固体油脂包括:12份乳木果油、5份单甘脂、11份月桂醇。Solid fats include: 12 parts shea butter, 5 parts monoglyceride, 11 parts lauryl alcohol.
液体油脂包括:4份辛酸癸酸甘油三酯、4份棕榈酸异辛酯。Liquid oils include: 4 parts caprylic capric triglyceride, 4 parts isooctyl palmitate.
乳化剂为:2份的司盘83、2份的吐温80,The emulsifier is: 2 parts of
再加入20份去离子水补足重量份数。Then add 20 parts of deionized water to make up the parts by weight.
步骤4:制备油相Step 4: Prepare the Oil Phase
将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温70℃,得到油相;The whitening active ingredient, the soothing active ingredient and the components of the oil phase in step 3 are heated and stirred to dissolve, and kept at 70°C to obtain the oil phase;
步骤5:制备水相Step 5: Prepare the Water Phase
将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温70℃,得到水相;Heat and stir the emulsifier and deionized water in step 3 to dissolve, keep warm at 70°C to obtain the water phase;
步骤6:制备初乳Step 6: Prepare Colostrum
将由步骤5得到的水相在剪切力为10000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质5min,得到初乳;Slowly add the water phase obtained in step 5 to the oil phase obtained in step 4 under the shear force of 10000r/min, and then homogenize for 5 minutes to obtain colostrum;
步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers
将步骤6得到的初乳,通过高压均质机在压力为600bar作用下均质4次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 is homogenized 4 times by a high-pressure homogenizer under the action of a pressure of 600 bar, and rapidly cooled to room temperature to obtain a whitening and soothing nano-structured lipid carrier.
检测美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。The particle size of the whitening and soothing nano-structured lipid carrier is detected to be between 200nm and 600nm.
实施例4Example 4
制备紫玉兰叶提取物和库拉索芦荟提取物的步骤不再重复。The steps for preparing the magnolia leaf extract and the aloe vera extract are not repeated.
步骤3:物料准备Step 3: Material Preparation
按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:
美白活性成分包括:8份α-熊果苷、6份白藜芦醇。Whitening active ingredients include: 8 parts of α-arbutin, 6 parts of resveratrol.
舒缓活性成分包括:7份紫玉兰叶提取物、8份库拉索芦荟提取物。Soothing active ingredients include: 7 parts Magnolia Leaf Extract, 8 parts Aloe Vera Extract.
油相的组分包括固体油脂和液体油脂。The components of the oil phase include solid fats and liquid fats.
固体油脂包括:12份乳木果油、7份单甘脂、11份月桂醇。Solid fats include: 12 parts shea butter, 7 parts monoglyceride, 11 parts lauryl alcohol.
液体油脂包括:2份辛酸癸酸甘油三酯、4份棕榈酸异辛酯。Liquid oils include: 2 parts caprylic capric triglyceride, 4 parts isooctyl palmitate.
乳化剂为:2份的司盘83、1份的吐温80,The emulsifier is: 2 parts of Span 83, 1 part of
再加入32份去离子水补足重量份数。Then add 32 parts of deionized water to make up the parts by weight.
步骤4:制备油相Step 4: Prepare the Oil Phase
将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温75℃,得到油相;Heat and stir the whitening active ingredient, soothing active ingredient and components of the oil phase in step 3 to dissolve, and keep warm at 75°C to obtain the oil phase;
步骤5:制备水相Step 5: Prepare the Water Phase
将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温75℃,得到水相;Heat and stir the emulsifier and deionized water in step 3 to dissolve, keep warm at 75°C to obtain the water phase;
步骤6:制备初乳Step 6: Prepare Colostrum
将由步骤5得到的水相在剪切力为12000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质4min,得到初乳;Slowly add the water phase obtained in step 5 to the oil phase obtained in step 4 under the shear force of 12000r/min, and then homogenize for 4 minutes to obtain colostrum;
步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers
将步骤6得到的初乳,通过高压均质机在压力为700bar作用下均质4次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 was homogenized four times by a high-pressure homogenizer at a pressure of 700 bar, and cooled rapidly to room temperature to obtain a whitening and soothing nanostructured lipid carrier.
检测美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。The particle size of the whitening and soothing nano-structured lipid carrier is detected to be between 200nm and 600nm.
实施例5Example 5
制备紫玉兰叶提取物和库拉索芦荟提取物的步骤不再重复。The steps for preparing the magnolia leaf extract and the aloe vera extract are not repeated.
步骤3:物料准备Step 3: Material Preparation
按合计重量100份计算物料为:According to the total weight of 100 parts, the material is:
美白活性成分包括:10份α-熊果苷、10份白藜芦醇。Whitening active ingredients include: 10 parts of α-arbutin, 10 parts of resveratrol.
舒缓活性成分包括:7份紫玉兰叶提取物、12份库拉索芦荟提取物。Soothing active ingredients include: 7 parts Magnolia Leaf Extract, 12 parts Aloe Vera Extract.
油相的组分包括固体油脂和液体油脂。The components of the oil phase include solid fats and liquid fats.
固体油脂包括:12份乳木果油、7份单甘脂、11份月桂醇。Solid fats include: 12 parts shea butter, 7 parts monoglyceride, 11 parts lauryl alcohol.
液体油脂包括:2份辛酸癸酸甘油三酯、4份棕榈酸异辛酯。Liquid oils include: 2 parts caprylic capric triglyceride, 4 parts isooctyl palmitate.
乳化剂为:2份的司盘83、2份的吐温80,The emulsifier is: 2 parts of
再加入21份去离子水补足重量份数。Then add 21 parts of deionized water to make up the parts by weight.
步骤4:制备油相Step 4: Prepare the Oil Phase
将步骤3中的美白活性成分、舒缓活性成分和油相的组分,加热搅拌溶解,保温65℃,得到油相;Heat and stir the whitening active ingredient, soothing active ingredient and components of the oil phase in step 3 to dissolve, and keep warm at 65°C to obtain the oil phase;
步骤5:制备水相Step 5: Prepare the Water Phase
将步骤3中的乳化剂和去离子水,加热搅拌溶解,保温65℃,得到水相;Heat and stir the emulsifier and deionized water in step 3 to dissolve, keep warm at 65°C to obtain the water phase;
步骤6:制备初乳Step 6: Prepare Colostrum
将由步骤5得到的水相在剪切力为14000r/min作用下缓慢加入由步骤4得到的油相中,然后再均质6min,得到初乳;Slowly add the water phase obtained in step 5 to the oil phase obtained in step 4 under the shear force of 14000r/min, and then homogenize for 6 minutes to obtain colostrum;
步骤7:制备纳米结构脂质载体Step 7: Preparation of Nanostructured Lipid Carriers
将步骤6得到的初乳,通过高压均质机在压力为600bar作用下均质5次,迅速冷却至室温,得到美白舒缓的纳米结构脂质载体。The colostrum obtained in step 6 is homogenized 5 times by a high-pressure homogenizer under the action of a pressure of 600 bar, and rapidly cooled to room temperature to obtain a whitening and soothing nano-structured lipid carrier.
检测美白舒缓的纳米结构脂质载体的粒径在200~600nm之间。The particle size of the whitening and soothing nano-structured lipid carrier is detected to be between 200nm and 600nm.
实施例6Example 6
检测美白舒缓的纳米结构脂质载体对斑马鱼胚胎安全性的影响。Examination of the effect of whitening and soothing nanostructured lipid carriers on the safety of zebrafish embryos.
斑马鱼胚胎安全性评价原理:将128细胞期斑马鱼胚胎暴露于受试物稀释液中96hpf,而后于显微镜下观察并记录具有凝结、没有心跳或尾巴未脱离特征的死亡鱼胚胎数目,计算胚胎死亡率。Zebrafish embryo safety evaluation principle: Expose zebrafish embryos at the 128-cell stage to 96hpf in the dilution of the test substance, then observe and record the number of dead fish embryos with the characteristics of condensation, no heartbeat or tail detachment under the microscope, and calculate the number of embryos mortality rate.
操作步骤:在产卵盒中按照1:2雌雄比配鱼产卵,在早上开灯刺激雌雄鱼交配,交配30min后收集胚胎,并用养殖水冲洗。Operation steps: In the spawning box, fish are paired with a male-to-female ratio of 1:2 to spawn. In the morning, the light is turned on to stimulate the male and female fish to mate. After 30 minutes of mating, the embryos are collected and rinsed with breeding water.
将6hpf胚胎放到体视显微镜下观察,筛选发育正常可用于后续实验的胚胎。将胚胎放置于24孔板中,每孔20枚胚胎,设置三组重复,在不伤害胚胎的情况下除去孔板中标准稀释水,向每孔中迅速加入1mL一定浓度的美白舒缓的纳米结构脂质载体的溶液(样品1)、将美白舒缓的纳米结构脂质载体原料产物不经过任何操作,直接以同浓度的组分进行简单的搅拌配置成同样浓度的、未包覆活性物纳米结构脂质载体溶液(样品2)以及空白溶液。The 6hpf embryos were observed under a stereomicroscope, and embryos with normal development were screened for subsequent experiments. Place the embryos in a 24-well plate, 20 embryos per well, set up three repetitions, remove the standard dilution water in the well plate without harming the embryos, and quickly add 1mL of a certain concentration of whitening and soothing nanostructures to each well Lipid carrier solution (sample 1), the whitening and soothing nanostructured lipid carrier raw material product is directly mixed with the same concentration of components to form the same concentration, uncoated active nanostructure Lipid carrier solution (sample 2) and blank solution.
在28.5℃恒温培养箱中避光孵育,每天观察胚胎的发育情况,及时移走死亡胚胎,更换100%药液,以免影响胚胎发育。暴露至96hpf后,观察记录胚胎的死亡数,计算死亡率。结果如图1所示。(P<0.01**;P<0.001***)。Incubate in the dark in a constant temperature incubator at 28.5°C, observe the development of the embryos every day, remove the dead embryos in time, and replace 100% of the drug solution, so as not to affect the development of the embryos. After exposure to 96hpf, the death number of embryos was observed and recorded, and the mortality rate was calculated. The result is shown in Figure 1. (P<0.01**; P<0.001***).
实施例7:Embodiment 7:
检测美白舒缓的纳米结构脂质载体对斑马鱼胚胎的美白功效影响Examination of the effect of whitening and soothing nanostructured lipid carrier on the whitening efficacy of zebrafish embryos
斑马鱼胚胎美白功效性评价原理:将24hpf的斑马鱼胚胎置于不同浓度受试物稀释液中至48hpf,根据黑色素在胚胎体表的沉积分布,观察黑色素颗粒分布的变化。Efficacy evaluation principle of zebrafish embryo whitening: place 24hpf zebrafish embryos in diluents of different concentrations of test substances to 48hpf, and observe the changes in the distribution of melanin granules according to the deposition and distribution of melanin on the embryo body surface.
操作步骤:在产卵盒中按照1:2雌雄比配鱼产卵,在早上开灯刺激雌雄鱼交配,交配30min后收集胚胎,并用养殖水冲洗。Operation steps: In the spawning box, fish are paired with a male-to-female ratio of 1:2 to spawn. In the morning, the light is turned on to stimulate the male and female fish to mate. After 30 minutes of mating, the embryos are collected and rinsed with breeding water.
放到体视显微镜下观察,筛选发育正常可用于后续实验的胚胎。选取发育正常的24hpf斑马鱼胚胎,放置于24孔板中,每孔20枚,设置三组重复,在不伤害胚胎的情况下除去孔板中标准稀释水,向每孔中迅速加入1mL一定浓度的美白舒缓的纳米结构脂质载体溶液以及空白溶液。Observe under a stereomicroscope to screen embryos that develop normally and can be used for subsequent experiments. Select 24hpf zebrafish embryos with normal development, place them in a 24-well plate, 20 embryos per well, set up three replicates, remove the standard dilution water in the well plate without harming the embryos, and quickly add 1mL of a certain concentration to each well Whitening and soothing nanostructured lipid carrier solution and blank solution.
在28.5℃恒温培养箱中避光孵育,孵育24hpf后,从表型和行为正常的斑马鱼中随机选取至少10尾斑马鱼,用3%甲基纤维素固定,在荧光显微镜下观察并拍照,使用图像分析软件对斑马鱼图片进行分析,以此来计算斑马鱼黑色素含量。结果如图2所示。(P<0.01**;P<0.001***;P<0.0001****)。结果表明,本发明的美白舒缓的纳米结构脂质载体,可明显抑制斑马鱼体表黑色素,具有显著地美白效果。Incubate in a constant temperature incubator at 28.5°C in the dark. After incubation for 24hpf, at least 10 zebrafish were randomly selected from zebrafish with normal phenotype and behavior, fixed with 3% methylcellulose, observed and photographed under a fluorescent microscope, Use image analysis software to analyze the zebrafish pictures to calculate the melanin content of the zebrafish. The result is shown in Figure 2. (P<0.01**; P<0.001***; P<0.0001****). The results show that the whitening and soothing nano-structured lipid carrier of the present invention can obviously inhibit the melanin on the body surface of zebrafish, and has a remarkable whitening effect.
实验例8Experimental example 8
检测美白舒缓的纳米结构脂质载体对斑马鱼胚胎的舒缓功效影响Testing the soothing efficacy of whitening and soothing nanostructured lipid carriers on zebrafish embryos
斑马鱼胚胎舒缓功效性评价原理:将24hpf的斑马鱼胚胎置于不同浓度受试物稀释液中,孵育一段时间后,观察胚胎的翻滚情况,以此评价受试物的舒缓功效情况。The principle of evaluating the soothing efficacy of zebrafish embryos: place 24hpf zebrafish embryos in diluents of different concentrations of the test substance, and after incubation for a period of time, observe the rolling of the embryos to evaluate the soothing effect of the test substance.
操作步骤:在产卵盒中按照1:2雌雄比配鱼产卵,在早上开灯刺激雌雄鱼交配,交配30min后收集胚胎,并用养殖水冲洗。放到体视显微镜下观察,筛选发育正常可用于后续实验的胚胎。Operation steps: In the spawning box, fish are paired with a male-to-female ratio of 1:2 to spawn. In the morning, the light is turned on to stimulate the male and female fish to mate. After 30 minutes of mating, the embryos are collected and rinsed with breeding water. Observe under a stereomicroscope to screen embryos that develop normally and can be used for subsequent experiments.
选取发育正常的24hpf斑马鱼胚胎,放置于96孔板中,每孔5枚胚胎,设置3组重复,在不伤害胚胎的情况下除去孔板中标准稀释水,并加入不同浓度美白舒缓的纳米结构脂质载体的稀释液,空白对照组和模型对照组加入缓冲水,阳性对照组加入造模剂,孵育一个小时,孵育结束后除去孔中液体,空白组加入缓冲水,模型组加入SDS溶液,受试物中加入造模剂配制的溶液,孵育15min后,记录每枚胚胎在30s内翻滚次数。结果如图3所示。Select 24hpf zebrafish embryos with normal development, place them in a 96-well plate, 5 embryos per well, set up 3 groups of repetitions, remove the standard dilution water in the well plate without harming the embryos, and add different concentrations of whitening and soothing nano Dilution of structured lipid carrier, add buffer water to the blank control group and model control group, add modeling agent to the positive control group, incubate for one hour, remove the liquid in the well after incubation, add buffer water to the blank group, and add SDS solution to the model group , adding the solution prepared by the modeling agent to the test substance, and after incubation for 15 minutes, record the number of times each embryo rolled over within 30 seconds. The result is shown in Figure 3.
结果表明,本发明的美白舒缓的纳米结构脂质载体,可明显减少斑马鱼胚胎的翻滚次数,具有显著地舒缓效果。The results show that the whitening and soothing nano-structured lipid carrier of the present invention can significantly reduce the number of tumbling times of zebrafish embryos, and has a significant soothing effect.
实施例9:一种美白乳液(美白舒缓的纳米结构脂质载体的应用)Embodiment 9: A kind of whitening emulsion (the application of nanostructure lipid carrier that whitens and relieves)
以美白舒缓的纳米结构脂质载体作为关键组分制备美白乳液,按质量百分比计包括以下组分:The whitening emulsion is prepared with the whitening and soothing nano-structured lipid carrier as the key component, which includes the following components by mass percentage:
制备方法:Preparation:
将A相、B相、C相的各个组分分别搅拌混合后备用。首先将A和B两相分别加热至80℃,溶解混合均匀,将A相加入到B相中,并均质5min,在转速为8000rpm/min搅拌,随后冷却至50℃时,加入C相并均质2min,陈化24h后包装即可。Stir and mix the components of Phase A, Phase B and Phase C separately and set aside for later use. First, heat A and B phases to 80°C respectively, dissolve and mix evenly, add phase A into phase B, and homogenize for 5 minutes, stir at a speed of 8000rpm/min, then cool to 50°C, add phase C and mix Homogenize for 2 minutes, pack after aging for 24 hours.
实施例10:一种美白面膜液(美白舒缓的纳米结构脂质载体的应用)Embodiment 10: A kind of whitening mask liquid (the application of nanostructure lipid carrier that whitens and relieves)
以美白舒缓的纳米结构脂质载体作为关键组分制备美白面膜液,按质量百分比计包括以下组分:The whitening mask liquid is prepared with the whitening and soothing nano-structured lipid carrier as the key component, which includes the following components by mass percentage:
制备方法:Preparation:
将A相、B相、C相的各个组分分别搅拌混合后备用。依次将A、B两相称好,将A和B相加热至80℃,溶解到无颗粒,转速为1000rpm/min搅拌均匀,将B相加入到A相中,均质5min,搅拌降温至50℃,加入C相,转速为800rpm/min低速均质2min,陈化24h后包装即可。Stir and mix the components of Phase A, Phase B and Phase C separately and set aside for later use. Mix phases A and B in turn, heat phases A and B to 80°C, dissolve until there are no particles, stir at a speed of 1000rpm/min, add phase B to phase A, homogenize for 5min, stir and cool down to 50°C , add phase C, homogenize at a low speed of 800rpm/min for 2min, age for 24h and pack.
实施例11,人体试用评价实验Embodiment 11, human body trial evaluation experiment
1.实验方法1. Experimental method
以实施例9:一种美白乳液(美白舒缓的纳米结构脂质载体的应用);实施例10:一种美白面膜液(美白舒缓的纳米结构脂质载体的应用)进行人体试用评价。Example 9: a whitening emulsion (application of whitening and soothing nanostructured lipid carrier); embodiment 10: a whitening mask liquid (application of whitening and soothing nanostructured lipid carrier) for human trial evaluation.
选取18~60岁的志愿者50名,分为两组。使用方法为每日洁面后使用,每天两次(早晚各涂一次),一组的左脸使用按实施例9制备的乳液,一组的左脸使用按实施例10制备的面膜液;两组的右脸使用其平时日常使用的一种无任何特殊功效(特别是不具备任何美白或舒缓成分)的基础护肤品(记录具体产品名称及型号)。Select 50 volunteers aged 18-60 and divide them into two groups. The method of use is to use after cleansing every day, twice a day (respectively apply once in the morning and evening), the left face of one group uses the emulsion prepared by embodiment 9, and the left face of one group uses the facial mask liquid prepared by
实验期为两个月,试验期间受试部位不使用其他化妆品,使用两个月后观察左脸和右脸的肤色和斑点、暗沉情况以及肌肤的敏感性。The test period is two months. During the test period, no other cosmetics are used on the test site. After two months of use, the skin color, spots, dullness and skin sensitivity of the left and right faces are observed.
2.实验结果2. Experimental results
使用两个月后发现,有合计44名志愿者使用了按实施例9制备的乳液、按实施例10制备的面膜液的左脸的肤色都能够好于其右脸,并且左脸的斑点和暗沉情况明显改善,同时,肌肤的抗敏性提高。可以认为该有效率高达88%。After two months of use, it was found that a total of 44 volunteers had used the emulsion prepared in Example 9 and the skin color of the facial mask liquid prepared in Example 10. The skin color of the left face can be better than that of the right face, and the spots and The dullness is significantly improved, and at the same time, the skin's anti-sensitivity is improved. It is considered that the effective rate is as high as 88%.
本发明所制备的美白舒缓的纳米结构脂质载体可广泛应用到化妆品领域中,如膏霜、乳液、精华液、面膜等不同剂型的化妆品中,或美白、抗炎、抗衰、保湿等不同功效化妆品中,具有较好的应用价值。The whitening and soothing nanostructured lipid carrier prepared by the present invention can be widely used in the field of cosmetics, such as creams, lotions, essences, facial masks and other cosmetics of different formulations, or different formulations such as whitening, anti-inflammatory, anti-aging, moisturizing, etc. In functional cosmetics, it has good application value.
最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。Finally, it should be noted that: the above embodiments are only used to illustrate the technical solutions of the present invention, rather than limiting them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: It is still possible to modify the technical solutions described in the foregoing embodiments, or perform equivalent replacements for some or all of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the technical solutions of the various embodiments of the present invention. scope.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211056118.7A CN115350133A (en) | 2022-08-29 | 2022-08-29 | Preparation and application of skin-whitening and soothing nano-structure lipid carrier |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211056118.7A CN115350133A (en) | 2022-08-29 | 2022-08-29 | Preparation and application of skin-whitening and soothing nano-structure lipid carrier |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115350133A true CN115350133A (en) | 2022-11-18 |
Family
ID=84004960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211056118.7A Pending CN115350133A (en) | 2022-08-29 | 2022-08-29 | Preparation and application of skin-whitening and soothing nano-structure lipid carrier |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115350133A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107115232A (en) * | 2017-04-25 | 2017-09-01 | 广州雅纯化妆品制造有限公司 | A kind of liquid of releiving of refreshing oneself applied to cosmetics |
CN109646376A (en) * | 2019-01-25 | 2019-04-19 | 金怡文 | A kind of whitening moisturizing face masque and preparation method thereof |
CN110664643A (en) * | 2019-10-30 | 2020-01-10 | 长春市奢脉嘉天化妆品有限公司 | Polypeptide essence with multiple-effect whitening effect and preparation method thereof |
CN114010546A (en) * | 2021-11-19 | 2022-02-08 | 广东轻工职业技术学院 | Multi-load whitening synergistic nanostructured lipid carrier and preparation method thereof |
CN114712274A (en) * | 2021-12-23 | 2022-07-08 | 上海交通大学医学院附属第九人民医院 | Soothing and anti-allergy nano vesicle composition and application thereof |
CN114886813A (en) * | 2022-05-27 | 2022-08-12 | 广州环亚化妆品科技股份有限公司 | Anti-aging plant extract composition and preparation method and application thereof |
-
2022
- 2022-08-29 CN CN202211056118.7A patent/CN115350133A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107115232A (en) * | 2017-04-25 | 2017-09-01 | 广州雅纯化妆品制造有限公司 | A kind of liquid of releiving of refreshing oneself applied to cosmetics |
CN109646376A (en) * | 2019-01-25 | 2019-04-19 | 金怡文 | A kind of whitening moisturizing face masque and preparation method thereof |
CN110664643A (en) * | 2019-10-30 | 2020-01-10 | 长春市奢脉嘉天化妆品有限公司 | Polypeptide essence with multiple-effect whitening effect and preparation method thereof |
CN114010546A (en) * | 2021-11-19 | 2022-02-08 | 广东轻工职业技术学院 | Multi-load whitening synergistic nanostructured lipid carrier and preparation method thereof |
CN114712274A (en) * | 2021-12-23 | 2022-07-08 | 上海交通大学医学院附属第九人民医院 | Soothing and anti-allergy nano vesicle composition and application thereof |
CN114886813A (en) * | 2022-05-27 | 2022-08-12 | 广州环亚化妆品科技股份有限公司 | Anti-aging plant extract composition and preparation method and application thereof |
Non-Patent Citations (5)
Title |
---|
丁林芬等: ""紫玉兰叶中木脂素类成分及抗炎活性研究"", 《中草药》, vol. 53, no. 13, 6 July 2022 (2022-07-06), pages 3912 - 3919 * |
万德光主编: "《中药品种品质与药效》", 31 December 2007, 上海科学技术出版社, pages: 539 - 541 * |
书金等编著: "《塑造丽人完美肌肤》", 31 July 2004, 吉林大学出版社, pages: 156 * |
李峰等: ""紫玉兰叶油化学成分的气相色谱/质谱法分析"", 《分析化学》, no. 07, 25 July 2000 (2000-07-25), pages 829 - 832 * |
谭志坚: ""双水相萃取体系在分离纯化芦荟活性成分中的应用研究"", 《中国博士学位论文全文数据库》, 15 February 2014 (2014-02-15), pages 1 - 149 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10004678B2 (en) | Anti-dandruff compositions, and methods of use thereof | |
JP7275103B2 (en) | Novel cosmetic use of Nephelium lapaceum extract | |
JP6387219B2 (en) | Skin external preparation composition containing tangeretin and EGCG | |
FR2684300A1 (en) | COSMETIC OR PHARMACEUTICAL COMPOSITION, PARTICULARLY DERMATOLOGICAL, IN PARTICULAR FOR PROMOTING THE PIGMENTATION OF SKIN OR HAIR, CONTAINING A BALLOTE EXTRACT, AND METHOD FOR PRODUCING THE SAME. | |
CN115074393A (en) | Pichia pastoris fermentation lysate filtrate, preparation method and application | |
CN106994135A (en) | Sea grape extract with function of inhibiting allergy, preparation method and application | |
WO2001074326A1 (en) | Agents improving skin barrier function | |
US10898429B2 (en) | Uses of coffee pulp extract | |
JP2000044485A (en) | Active oxygen species scavenger and skin cosmetic | |
WO2022164804A1 (en) | Nano- or micro-emulsion compositions and methods of use thereof | |
CN115350133A (en) | Preparation and application of skin-whitening and soothing nano-structure lipid carrier | |
KR100532633B1 (en) | Cosmetic composition having anti-inflammatory, skin-protecting, skin-elastic effects which comprise mixed plants extract | |
JP2002037709A (en) | Skin care preparation | |
WO2015036704A1 (en) | Cosmetic or dermatological use of an extract of tapirira guianensis | |
US20240156716A1 (en) | Cosmetic use of a solanum lycopersicum fruit (tomato) skin extract | |
Xu et al. | An ionic liquid nanoparticles for dermal targeted delivery and effective anti-wrinkle treatment | |
JP3611553B2 (en) | Skin preparation | |
CN118178285A (en) | Application of Sorbus nigra extract in skin care product and cosmetics | |
CN115414286A (en) | Cosmetic composition for skin allergy relief containing Phaeodactylum tricornutum complex extract as active ingredient | |
WO2023161288A1 (en) | Moabi cake hydrolysate and preparation method and cosmetic use thereof, particularly for the treatment of ageing skin and skin depigmentation | |
FR3145488A1 (en) | Cosmetic use of a combination of plant extracts. | |
WO2024023440A1 (en) | Novel cosmetic or dermatological use of a gentiana crassicaulis extract | |
CN118267313A (en) | Bionic nano chlorophyll wrapped by fat-soluble biological film, preparation method thereof and application of bionic nano chlorophyll in anti-atrophy photoaging | |
KR20220042759A (en) | Composition for preventing or treating hair loss comprising spirulina extract | |
CN117412755A (en) | Compositions comprising plant-derived exosome-like nanovesicles or exosomes and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |